| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
long intergenic non-protein coding RNA 970 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 1 | 97 | 2012 | 2012 | |||||||||
|
F11 antisense RNA 1 | 0.805 | 0.308 |
|
phenotype | 0.100 | None | 1.000 | 1 | 16 | 2012 | 2012 | |||||||||
|
IL12A antisense RNA 1 | 0.633 | 0.654 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
selectin P | 0.460 | 0.769 | 5.0E-32 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
endoplasmic reticulum aminopeptidase 1 | 0.556 | 0.692 | 2.1E-26 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
coagulation factor XI | 0.590 | 0.692 | 3.6E-26 |
|
phenotype | 0.100 | None | 1.000 | 1 | 14 | 2012 | 2012 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
serine/threonine kinase like domain containing 1 | 0.931 | 0.115 | 1.6E-23 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
protein Z, vitamin K dependent plasma glycoprotein | 0.792 | 0.385 | 1.2E-16 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
phenotype | 0.500 | None | 1.000 | 22 | 11 | 2002 | 2012 | ||||||||
|
MEFV innate immuity regulator, pyrin | 0.440 | 0.885 | 1.0E-14 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
fibrinogen alpha chain | 0.573 | 0.769 | 1.2E-13 |
|
phenotype | 0.300 | None | 1.000 | 2 | 1 | 2012 | 2013 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
protein tyrosine phosphatase receptor type J | 0.606 | 0.615 | 1.3E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
complement C4A (Rodgers blood group) | 0.563 | 0.769 | 1.5E-11 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
serpin family A member 10 | 0.805 | 0.192 | 4.2E-11 |
|
phenotype | 0.310 | None | 1.000 | 2 | 0 | 2004 | 2006 |